Yuan, Chen
Ng, Kimmie
Article History
Received: 17 February 2020
Revised: 26 May 2020
Accepted: 9 June 2020
First Online: 6 July 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: K.N. declares research funding from Evergrande Group, Genentech, Gilead Sciences, Pharmavite, Revolution Medicines, Tarrex Biopharma, and Trovagene; advisory board participation for Array Biopharma, Bayer, Eli Lilly and Company, Genentech, and Seattle Genetics; and consulting for Tarrex Biopharma. C.Y. declares no conflicts of interest.
: The SUNSHINE clinical trial was supported by P50CA127003, R01CA205406, and R01CA118553 from the National Institutes of Health, National Cancer Institute; Gloria Spivak Faculty Advancement Award; Friends of Dana-Farber Cancer Institute Award; Project P Fund; Consano; Pharmavite; and Genentech. C.Y. and K.N. are supported by the Pussycat Foundation Helen Gurley Brown Presidential Initiative.